Mühlmeier Guido, Tisch Matthias
Klinik für Hals-Nasen-Ohren-Heilkunde, Kopf- und Halschirurgie, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081, Ulm, Deutschland.
HNO. 2022 Sep;70(9):685-690. doi: 10.1007/s00106-022-01202-9. Epub 2022 Aug 2.
Intratympanic steroids are a therapeutic component in sudden hearing loss related to cochlear affection. Little has been published on patients' acceptance and tolerance to date.
A total of 84 patients were asked about health conditions and circumstances surrounding their intratympanic therapy.
The patients comprised 38 women and 46 men, aged 57.2 years on average, who had mostly been referred by their ENT physician for second-line treatment. Reported were injection pain by 3.6%, discomfort by 22.6%, tolerability by 67.9%, and painlessness by 41.7% (more than one answer possible). Whereas 77.4% recommended intratympanic treatment, reasons for no recommendation were lack of efficacy and an unpleasant sensation.
The majority of patients rated intratympanic therapy as bearable and recommendable. Close patient guidance seems to be an important part of the treatment.
鼓室内注射类固醇是与耳蜗病变相关的突发性听力损失的一种治疗手段。迄今为止，关于患者的接受度和耐受性的报道较少。
共询问了84例患者关于其鼓室内治疗的健康状况及相关情况。
患者包括38名女性和46名男性，平均年龄57.2岁，大多由耳鼻喉科医生转诊进行二线治疗。报告的注射疼痛发生率为3.6%，不适发生率为22.6%，耐受性发生率为67.9%，无痛发生率为41.7%（可能有多个答案）。77.4%的患者推荐鼓室内治疗，不推荐的原因是缺乏疗效和感觉不适。
大多数患者认为鼓室内治疗是可耐受且值得推荐的。密切的患者指导似乎是治疗的重要组成部分。
